Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Commonwealth Alternative Care (CAC) is a vertically integrated cannabis company based in Massachusetts, specializing in the cultivation, processing, and retail of medical and adult-use marijuana. The company operates a state-of-the-art 100,000-square-foot facility in Taunton for cultivation and advanced extraction, utilizing hydrocarbon, CO2, and ethanol methods. CAC produces a diverse range of pharmaceutical-grade cannabis products, including flower, concentrates, vape cartridges, and edibles. As a subsidiary of TILT Holdings, the company adheres to rigorous laboratory testing standards to ensure product safety and efficacy for patients and consumers. CAC serves the Massachusetts market through its retail dispensaries located in Taunton, Brockton, and Cambridge. Their business model focuses on providing high-quality cannabis-based therapies and comprehensive patient education.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Commonwealth Alternative Care.